Selected research
Market Structure
Global HMO Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global HMO Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for HMO Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for HMO Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HMO Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for HMO Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of HMO Formula include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso) and Yili Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global HMO Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of HMO Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents HMO Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HMO Formula market size, projected growth trends, production technologies, key applications, and end-use industries.
HMO Formula Segment by Company
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
HMO Formula Segment by Type
Powder
Liquid
HMO Formula Segment by Application
Online Sales
Offline Sales
HMO Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMO Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HMO Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMO Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the HMO Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HMO Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HMO Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of HMO Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Liquid
Applications
- Online Sales
- Offline Sales
Companies covered
- Abbott
- Mead Johnson (Reckitt)
- Nestlé
- Danone
- FrieslandCampina(Friso)
- Yili Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global HMO Formula Market Size, 2021 VS 2025 VS 2032
- 1.3 Global HMO Formula Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global HMO Formula Sales Estimates and Forecasts (2021-2032)
- 1.5 Global HMO Formula Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global HMO Formula Market Dynamics
- 2.1 HMO Formula Industry Trends
- 2.2 HMO Formula Industry Drivers
- 2.3 HMO Formula Industry Opportunities and Challenges
- 2.4 HMO Formula Industry Restraints
3 HMO Formula Market by Manufacturers
- 3.1 Global HMO Formula Revenue by Manufacturers (2021-2026)
- 3.2 Global HMO Formula Sales by Manufacturers (2021-2026)
- 3.3 Global HMO Formula Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global HMO Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global HMO Formula Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global HMO Formula Manufacturers, Product Type & Application
- 3.7 Global HMO Formula Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global HMO Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 HMO Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 HMO Formula Tier 1, Tier 2, and Tier 3
4 HMO Formula Market by Type
- 4.1 HMO Formula Type Introduction
- 4.1.1 Powder
- 4.1.2 Liquid
- 4.2 Global HMO Formula Sales by Type
- 4.2.1 Global HMO Formula Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global HMO Formula Sales by Type (2021-2032)
- 4.2.3 Global HMO Formula Sales Market Share by Type (2021-2032)
- 4.3 Global HMO Formula Revenue by Type
- 4.3.1 Global HMO Formula Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global HMO Formula Revenue by Type (2021-2032)
- 4.3.3 Global HMO Formula Revenue Market Share by Type (2021-2032)
5 HMO Formula Market by Application
- 5.1 HMO Formula Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global HMO Formula Sales by Application
- 5.2.1 Global HMO Formula Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global HMO Formula Sales by Application (2021-2032)
- 5.2.3 Global HMO Formula Sales Market Share by Application (2021-2032)
- 5.3 Global HMO Formula Revenue by Application
- 5.3.1 Global HMO Formula Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global HMO Formula Revenue by Application (2021-2032)
- 5.3.3 Global HMO Formula Revenue Market Share by Application (2021-2032)
6 Global HMO Formula Sales by Region
- 6.1 Global HMO Formula Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global HMO Formula Sales by Region (2021-2032)
- 6.2.1 Global HMO Formula Sales by Region (2021-2026)
- 6.2.2 Global HMO Formula Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America HMO Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America HMO Formula Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe HMO Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe HMO Formula Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific HMO Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific HMO Formula Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa HMO Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa HMO Formula Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global HMO Formula Revenue by Region
- 7.1 Global HMO Formula Revenue by Region
- 7.1.1 Global HMO Formula Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global HMO Formula Revenue by Region (2021-2026)
- 7.1.3 Global HMO Formula Revenue by Region (2027-2032)
- 7.1.4 Global HMO Formula Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America HMO Formula Revenue (2021-2032)
- 7.2.2 North America HMO Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe HMO Formula Revenue (2021-2032)
- 7.3.2 Europe HMO Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific HMO Formula Revenue (2021-2032)
- 7.4.2 Asia-Pacific HMO Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa HMO Formula Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa HMO Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott HMO Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott HMO Formula Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Mead Johnson (Reckitt)
- 8.2.1 Mead Johnson (Reckitt) Company Information
- 8.2.2 Mead Johnson (Reckitt) Business Overview
- 8.2.3 Mead Johnson (Reckitt) HMO Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mead Johnson (Reckitt) HMO Formula Product Portfolio
- 8.2.5 Mead Johnson (Reckitt) Recent Developments
- 8.3 Nestlé
- 8.3.1 Nestlé Company Information
- 8.3.2 Nestlé Business Overview
- 8.3.3 Nestlé HMO Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Nestlé HMO Formula Product Portfolio
- 8.3.5 Nestlé Recent Developments
- 8.4 Danone
- 8.4.1 Danone Company Information
- 8.4.2 Danone Business Overview
- 8.4.3 Danone HMO Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Danone HMO Formula Product Portfolio
- 8.4.5 Danone Recent Developments
- 8.5 FrieslandCampina(Friso)
- 8.5.1 FrieslandCampina(Friso) Company Information
- 8.5.2 FrieslandCampina(Friso) Business Overview
- 8.5.3 FrieslandCampina(Friso) HMO Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 FrieslandCampina(Friso) HMO Formula Product Portfolio
- 8.5.5 FrieslandCampina(Friso) Recent Developments
- 8.6 Yili Group
- 8.6.1 Yili Group Company Information
- 8.6.2 Yili Group Business Overview
- 8.6.3 Yili Group HMO Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Yili Group HMO Formula Product Portfolio
- 8.6.5 Yili Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 HMO Formula Value Chain Analysis
- 9.1.1 HMO Formula Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 HMO Formula Production Mode & Process
- 9.2 HMO Formula Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 HMO Formula Distributors
- 9.2.3 HMO Formula Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst